Studies on Chemotherapeutics for <i>Mycobacterium tuberculosis</i>. XXII

Genetical studies on the skeleton of the mouse. XXII. The development of Danforth's short-tail.

T H E semi-dominant gene for Danforth's short-tail in the mouse (symbol Sd; linkage group V) was first described by Dunn, Gluecksohn-Schoenheimer, & Bryson (1940). The most conspicuous abnormality of Sdl + heterozygotes is a shortening of the tail the extent of which varies with the genetic background (Dunn, 1942; Fisher & Holt, 1944; Dunn & Gluecksohn-Schoenheimer, 1945). Reduction or absence ...

Studies on echinococcosis XXII. Changes of serum titers in mice infected experimentally with E. multilocularis.

Antifungal chemotherapeutics.

This review addresses trends in outcome and risk factors for invasive fungal infections, current antifungal agents and new therapeutic strategies. Current prospects for new therapies rest upon caspofungin, the first of a new class of antifungal molecules, the echinocandins, and new extended-spectrum azoles, voriconazole, posaconazole and ravuconazole. Approval by the Food and Drug Administratio...

Nanoformulations of Antimicrobial Chemotherapeutics

Bacterial infections represent an increasing worldwide threat. The number of untreatable diseases decreased after the 1950s due to the introduction of antimicrobial agents. However, since the 1980s, morbidity has risen again, and mortality due to respiratory infections, AIDS and tuberculosis now represents about 85% of world mortality from infections [1,2]. The increase in the number of new inf...

Notes on Some Remedies. XXII. Blood Transfusion, Part I